Clene Inc. (CLNN)
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; ongoing Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a planned Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company's products also include CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.
$33.16M
Mr. Robert Etherington MBA
95.00
Salt Lake City, UT
Aug 27, 2018
-1.67
$-3.07
0.77
0.99
-6,890.50%
-22.31
-0.86
-1,348.36
77.44
0.99
-75.52%
-315.97%
Similar stocks (13)
Immunome, Inc.
IMNM
Nuvation Bio Inc.
NUVB
Eliem Therapeutics, Inc.
ELYM
Foghorn Therapeutics Inc.
FHTX
Nkarta, Inc.
NKTX
Century Therapeutics, Inc.
IPSC
Werewolf Therapeutics, Inc.
HOWL
MediciNova, Inc.
MNOV
Ikena Oncology, Inc.
IKNA
Champions Oncology, Inc.
CSBR
Kezar Life Sciences, Inc.
KZR
NextCure, Inc.
NXTC
Sensei Biotherapeutics, Inc.
SNSE
ETF Exposure (8)
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (13)
Immunome, Inc.
IMNM
Nuvation Bio Inc.
NUVB
Eliem Therapeutics, Inc.
ELYM
Foghorn Therapeutics Inc.
FHTX
Nkarta, Inc.
NKTX
Century Therapeutics, Inc.
IPSC
Werewolf Therapeutics, Inc.
HOWL
MediciNova, Inc.
MNOV
Ikena Oncology, Inc.
IKNA
Champions Oncology, Inc.
CSBR
Kezar Life Sciences, Inc.
KZR
NextCure, Inc.
NXTC
Sensei Biotherapeutics, Inc.
SNSE
ETF Exposure (8)
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%